[go: up one dir, main page]

CN105838759A - Preparation method of stevia sugar derivative - Google Patents

Preparation method of stevia sugar derivative Download PDF

Info

Publication number
CN105838759A
CN105838759A CN201610181707.6A CN201610181707A CN105838759A CN 105838759 A CN105838759 A CN 105838759A CN 201610181707 A CN201610181707 A CN 201610181707A CN 105838759 A CN105838759 A CN 105838759A
Authority
CN
China
Prior art keywords
compound
preparation
udpg
reaction
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610181707.6A
Other languages
Chinese (zh)
Inventor
朱惠霖
丁雪峰
张永正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING NUOYUN BIOTECHNOLOGY Co Ltd
Original Assignee
NANJING NUOYUN BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING NUOYUN BIOTECHNOLOGY Co Ltd filed Critical NANJING NUOYUN BIOTECHNOLOGY Co Ltd
Priority to CN201610181707.6A priority Critical patent/CN105838759A/en
Publication of CN105838759A publication Critical patent/CN105838759A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/56Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to a preparation method of a stevia sugar derivative and belongs to the technical field of food chemical engineering. With a stevia sugar derivative compound (I) as a substrate, a reaction is carried out under the catalysis of an UDP glucosyl transferase to the substrate to generate a stevia sugar derivative compound (IV) in the presence of a glucosyl group donor. The preparation method is green and safe, is low in production cost and short in period, greatly improves competitiveness of the product, is simple in operation, is high in conversion rate and is simple in purification. The product is high in purity, can be used in food and beverage industries, and has greatly application value.

Description

A kind of preparation method of stevioside derivant
Technical field
The present invention relates to the preparation method of a kind of stevioside derivant, belong to food chemistry technical field.
Background technology
Stevioside is a kind of new type natural sweeting agent extracted the leaf from catananche's Folium Stevlae Rebaudianae, stem, be a kind of natural, Green, the functional food of health care, it has fragrance, refrigerant taste, also has the feature that sugariness is high, heat energy is low, its sugariness It is 200-300 times of sucrose, and calorific value is only sucrose volume 1/300, be the ideal sweeting agent of a kind of alternative sucrose.Along with The mankind are known as, by Food Science man, the sweeting agent that future world is most with prospects to healthy, green attention, stevioside.
Stevioside is considered the good supplementary of the mankind and health care medicine by international medical community.Prove through a large amount of scientific experimentss, Stevioside is conducive to regulation blood glucose and blood pressure, the most edible regulating blood sugar level, and prophylaxis of hypertension improves hypostension; Stevioside also has some bacterial growth of suppression and breeding and the effect stoping it to infect, it is possible to treatment flu and influenza and pre-preventing decayed tooth The diseases such as tooth;Stevioside can reduce people's demand to sugar with fat, regulates its diet, reduces people's demand to tobacco and wine, Prevent the generation of the diseases such as diabetes, obesity, heart disease;Meanwhile, stevioside also has skin repair and improving effect, It can treat dermatosis, smoothes away wrinkles, and removes cicatrix etc..
Stevioside can be widely applied to the industries such as food, beverage, flavouring agent, medicine, daily-use chemical industry, wine brewing, cosmetics, relatively Use sucrose escapable cost about 60%, and be of high nutritive value.The stability of stevioside, metabolic pathway and safety thereof are by deeply Entering research, its China's Ministry of Public Health, Ministry of Light Industry's approval uses, and is also recognized as by U.S. food Drug Administration The rank of " GRAS (being commonly considered as safe) ".Stevioside is as the natural substitute of sucrose, and it has a extensive future.
Though stevioside has numerous advantage, but its serious bitter aftertaste, hinder its extensive application.At present, Flos Chrysanthemi The improvement of sugar mouthfeel can be realized by enzyme process bioconversion.Have been reported, it is possible to use cyclodextrin glycosyl transferases modification Flos Chrysanthemi Sugar, to improve its mouthfeel and taste matter, but the position of this enzyme transfer glycosyl is the most single-minded, and product is impure, and its sugariness the most seriously drops Low.
The double glycosides of Flos Chrysanthemi is converted into the reaction etc. of rebaudioside A and D to stevioside and the conversion of RB and stevioside.This Study for numerous components of stevioside a bit, the most very little, and also its modified mouthfeel and taste matter are also Pangs Big research.Seek efficient metabolizing enzymes, conversion process and Novel sweet inulin derivant and be still the research that stevioside is following Trend.
Summary of the invention
Present invention solves the technical problem that and be: propose a kind of cost that can be relatively low and the Flos Chrysanthemi of shorter production cycle output high-quality The preparation method of sugar derivatives, the method with compound (I) as raw material, under the catalytic action of UDPG based transferase Reaction generates stevioside derivative compound (IV).
In order to solve above-mentioned technical problem, the technical scheme that the present invention proposes is: the preparation method of a kind of compound (IV), With compound (I) as substrate, make described substrate in the presence of glucosyl group donor, at UDPG based transferase Reacting generating compound (IV) under catalytic action, described preparation method is as follows:
Preferably, described UDPG based transferase is carried by fermenting and producing portion of Nanjing Nuoyun Biological Technology Co., Ltd. Supply.
Preferably, the consumption of described UDPG is 0.0135~5.41g/L.
Preferably, in microbial hosts express UDPG based transferase, described microbial hosts selected from escherichia coli, Bacillus, yeast, aspergillosis or Pichia sp..
Preferably, described reaction is at MgCl2Concentration is 0~0.286g/L, and temperature is 20~37 DEG C, the water of pH5.0~9.0 Carrying out in phase system, the response time is 0.5~72h.
Preferably, described reaction is carried out in the Tris-HCl buffer of pH8.0.
Preferably, substrate initial concentration is 0.676~54.05g/L.
Preferably, take UDPG based transferase 444mg, use sterilized water re-suspended cell, and ultrasonic disruption is thin in ice bath Born of the same parents, are the crude enzyme liquid used by reaction;Precision weighs sample, is configured to 1.85ml system, and wherein the end of compound (I) is dense Degree 2.0g/L, UDPG are 2.70g/L, and add the MgCl of 0.286g/L2;It is subsequently adding crude enzyme liquid, and adds Tris-HCl PH of buffer 8.0 to system is 1.85ml, initial action;25 DEG C of constant-temperature tables vibrate 38h with 150rpm, and 100 DEG C are boiled end Only reaction, 13000g is centrifuged 10min, takes supernatant as sample, utilizes macroporous resin to carry out sample just and purify, and use LC-MS The purity of the compound that method detection purifies.
Beneficial effect:
The present invention with stevioside derivative compound (I) as substrate, make described substrate in the presence of glucosyl group donor, at UDP- Under the catalytic action of glucosyltransferase, reaction generates stevioside derivative compound (IV), production technology green safety, and life It is short to produce low cost, cycle, improves the competitiveness of product greatly.Owing to the present invention is easy and simple to handle, transformation efficiency is high, purifies and holds Easily, products obtained therefrom purity is high, can be used for bag and bottle industry, has important using value.
Accompanying drawing explanation
Below in conjunction with the accompanying drawings the present invention is described further.
Fig. 1 is the HPLC spectrogram of compound (IV)
Fig. 2 is the MS spectrogram of compound (IV)
Detailed description of the invention
The UDPG based transferase (i.e. uridine diphosphoglucose based transferase) of the present invention is had by Nanjing promise cloud biotechnology Fermenting and producing portion of limit company provides, and below UDPG based transferase is called for short M303.
Embodiment 1:
The structure of recombination bacillus coli and abduction delivering
Utilize molecular biology and technique for gene engineering etc. to obtain the expression of recombinant e. coli bacterial strain containing genes of interest, then will Recombination bacillus coli fermentation culture, the abduction delivering preparation reconstitution cell containing destination protein.It specifically comprises the following steps that
1) primer segments needed for synthesis, the UDPG based transferase M303 needed for being obtained by PCR amplification is encoded DNA fragmentation, and by homologous recombination technique, be incorporated in the expression cassette of pNYK expression vector.
2) by recombinant plasmid transformed to escherichia coli, it is thus achieved that the engineering bacteria J303 containing genes of interest.
3) being placed in TB culture medium by 1ml engineering bacteria J303,250rpm, 37 DEG C of shaken cultivation, to OD600=1.0, add Final concentration of 0.1mM IPTG is in 25 DEG C of shaken cultivation 16h.Induce after terminating with 10000g, 5min centrifugal collecting cell, put Store for future use in-80 DEG C.Obtain the thalline containing M303 albumen.
Embodiment 2:
Utilizing compound (I) is that substrate prepares compound (IV)
Take wet thallus M303 444mg, use sterilized water re-suspended cell, and ultrasonic disruption cell in ice bath, be reaction institute Crude enzyme liquid.Precision weighs sample, is configured to 1.85ml system, wherein substrate compounds (I) final concentration 2.0g/L, UDPG is 2.70g/L, and adds the MgCl of 0.286g/L2;It is subsequently adding crude enzyme liquid, and adds final concentration 0.1M's Tris-HCl buffer (pH8.0) to system is 1.85ml, initial action.25 DEG C of constant-temperature tables vibrate 38h with 150rpm, 100 DEG C are boiled termination reaction.13000g is centrifuged 10min, takes supernatant as sample, utilizes macroporous resin to carry out sample just and purifies, And use the purity of the compound (IV) of LC-MS method detection purification.
Embodiment 3:
The determination of best metal ion concentration
Thalline M303 444g in Example 1, according to the method in embodiment 2, is transferred in 5ml centrifuge tube, adds The compound (I) of final concentration of 2.0g/L, UDPG is 2.70g/L and MgCl2, and it is slow to add 0.1M Tris-HCl Rush liquid (pH8.0).As stated above, take Duplicate Samples, add MgCl2Final concentration be respectively 0,0.1,0.286g/L, instead After answering 38h, take after sample boils termination centrifugal, Supernatant samples is carried out HPLC analysis.Wherein MgCl2When being 0.286, Compound (IV) yield is the highest.·
Embodiment 4:
The determination of optimal reaction temperature
Thalline M303 444g in Example 1, according to the method in embodiment 2, is transferred in 5ml centrifuge tube, adds The Tris-HCl buffer (pH8.0) of final concentration of 0.1M, compound (I) is 2.0g/L, and UDPG is 2.70g/L. Taking Duplicate Samples as stated above, respectively at 20,25,30,37 DEG C, 150rpm carries out catalytic reaction, after reaction 30h, and sampling Product are centrifugal after boiling termination, and Supernatant samples is carried out HPLC analysis.Wherein temperature is 25 DEG C, and compound (IV) yield is the highest.
Embodiment 5:
The determination of optimum response pH
Thalline M303 444g in Example 1, according to the method in embodiment 2, is transferred in 5ml centrifuge tube, adds Entering the Tris-HCl buffer of final concentration of 0.1M, compound (I) is 2.0g/L, and UDPG is 2.70g/L.By upper The method of stating takes Duplicate Samples, and wherein pH is adjusted to 5.0,6.0,7.0,7.5,8.0,9.0 respectively.In 30 DEG C, 150rpm urges Change reaction, after reaction 38h, take sample and be centrifuged, Supernatant samples is carried out HPLC analysis.When wherein pH is 8.0, compound (IV) yield is the highest.
Embodiment 6:
Optimal substrate addition
Thalline M303 444g in Example 1, according to the method in embodiment 2, is transferred in 5ml centrifuge tube, adds The Tris-HCl buffer (pH8.0) of final concentration of 0.1M, UDPG is 2.70g/L.As stated above, take Duplicate Samples, And be separately added into final concentration of 0.676,0.901,1.35,2.0,5.41,13.51,27.03, the compound (I) of 54.05g/L. After reaction 38h, take after sample boils termination centrifugal, Supernatant samples is carried out HPLC analysis.When wherein adding 2.0g/L substrate, The yield of compound (IV) is the highest.
Embodiment 7:
Compound (IV) structural analysis
The method that the structure of compound (I) has been analyzed by carrying out hydrogen, carbon and ID NMR speetna resolves.Compound (I) Molecular weight (1127) is comparable to steviol and adds five glucoses, according to excess M303 enzyme exist characteristic i.e. in β-1,2 glycosidic bonds Add two glucose groups continuously and infer compound (IV) C62H100O38(1451.8) structure, and record molecule with LC Amount (1451) is confirmed.Compound (IV) molecular weight is comparable to steviol and adds 7 glucoses.
Above-described embodiment is only for technology design and the feature thereof of the explanation present invention, it is intended to those skilled in the art can easily be managed Solve present disclosure and implement according to this, can not limit the scope of the invention with this.In every case real according to spirit of the present invention The equivalence that matter is done changes or modifies, and all should contain within protection scope of the present invention.

Claims (8)

1. the preparation method of a compound (IV), it is characterised in that: with compound (I) as substrate, make the described end Thing in the presence of glucosyl group donor, reacting generating compound (IV) under the catalytic action of UDPG based transferase, Described preparation method is as follows:
The preparation method of compound the most according to claim 1 (IV), it is characterised in that: described UDP-Portugal Glucosyl transferase is provided by fermenting and producing portion of Nanjing Nuoyun Biological Technology Co., Ltd..
The preparation method of compound the most according to claim 1 (IV), it is characterised in that: described UDP-Portugal The consumption of grape sugar is 0.0135~5.41g/L.
The preparation method of compound the most according to claim 1 (IV), it is characterised in that: in microbial hosts Express UDPG based transferase, described microbial hosts selected from escherichia coli, bacillus, yeast, aspergillosis or Pichia sp..
The preparation method of compound the most according to claim 1 (IV), it is characterised in that: described reaction is at MgCl2 Concentration is 0~0.286g/L, and temperature is 20~37 DEG C, carries out in the aqueous phase system of pH5.0~9.0, the response time be 0.5~ 72h。
The preparation method of compound the most according to claim 5 (IV), it is characterised in that: described reaction is at pH8.0 Tris-HCl buffer in carry out.
The preparation method of compound the most according to claim 1 (IV), it is characterised in that: substrate initial concentration is 0.676~54.05g/L.
The preparation method of compound the most according to claim 7 (IV), it is characterised in that: take UDPG base and turn Move enzyme 444mg, use sterilized water re-suspended cell, and ultrasonic disruption cell in ice bath, be the crude enzyme liquid used by reaction;Essence Close weighing sample, be configured to 1.85ml system, wherein the final concentration 2.0g/L of compound (I), UDPG are 2.70g/L, And add the MgCl of 0.286g/L2;It is subsequently adding crude enzyme liquid, and to add Tris-HCl pH of buffer 8.0 to system is 1.85ml, Initial action;25 DEG C of constant-temperature tables vibrate 38h with 150rpm, and 100 DEG C are boiled termination reaction, and 13000g is centrifuged 10min, takes Supernatant, as sample, utilizes macroporous resin to carry out sample just and purifies, and uses the pure of compound that the detection of LC-MS method purifies Degree.
CN201610181707.6A 2016-03-28 2016-03-28 Preparation method of stevia sugar derivative Pending CN105838759A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610181707.6A CN105838759A (en) 2016-03-28 2016-03-28 Preparation method of stevia sugar derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610181707.6A CN105838759A (en) 2016-03-28 2016-03-28 Preparation method of stevia sugar derivative

Publications (1)

Publication Number Publication Date
CN105838759A true CN105838759A (en) 2016-08-10

Family

ID=56584747

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610181707.6A Pending CN105838759A (en) 2016-03-28 2016-03-28 Preparation method of stevia sugar derivative

Country Status (1)

Country Link
CN (1) CN105838759A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110656150A (en) * 2019-10-30 2020-01-07 山东三元生物科技股份有限公司 Preparation method of rebaudioside E, and product and application thereof
WO2020112957A1 (en) * 2018-11-27 2020-06-04 Purecircle Usa Inc. High-purity steviol glycosides
WO2020168312A1 (en) * 2019-02-15 2020-08-20 Purecircle Usa Inc. High-purity steviol glycosides
CN112512337A (en) * 2018-03-16 2021-03-16 谱赛科美国股份有限公司 High purity steviol glycosides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103974628A (en) * 2012-05-22 2014-08-06 谱赛科有限责任公司 High Purity Steviol Glycosides
CN104725438A (en) * 2013-12-18 2015-06-24 江南大学 Method for preparing sophorose
CN105348337A (en) * 2015-11-19 2016-02-24 南京诺云生物科技有限公司 Stevioside derivative prepared by stervioside biotransformation, preparation method and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103974628A (en) * 2012-05-22 2014-08-06 谱赛科有限责任公司 High Purity Steviol Glycosides
CN104725438A (en) * 2013-12-18 2015-06-24 江南大学 Method for preparing sophorose
CN105348337A (en) * 2015-11-19 2016-02-24 南京诺云生物科技有限公司 Stevioside derivative prepared by stervioside biotransformation, preparation method and application thereof

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112512337A (en) * 2018-03-16 2021-03-16 谱赛科美国股份有限公司 High purity steviol glycosides
JP2021518369A (en) * 2018-03-16 2021-08-02 ピュアサークル ユーエスエー インコーポレイテッド High-purity steviol glycoside
EP3764815A4 (en) * 2018-03-16 2022-01-26 PureCircle USA Inc. High-purity steviol glycosides
JP2024109659A (en) * 2018-03-16 2024-08-14 ピュアサークル ユーエスエー インコーポレイテッド Highly pure steviol glycosides
EP3887383A4 (en) * 2018-11-27 2022-11-09 PureCircle USA Inc. High-purity steviol glycosides
WO2020112957A1 (en) * 2018-11-27 2020-06-04 Purecircle Usa Inc. High-purity steviol glycosides
JP7634477B2 (en) 2018-11-27 2025-02-21 ピュアサークル ユーエスエー インコーポレイテッド High Purity Steviol Glycosides
CN113227111A (en) * 2018-11-27 2021-08-06 谱赛科美国股份有限公司 High-purity steviol glycosides
AU2019389030B2 (en) * 2018-11-27 2025-01-02 Purecircle Usa Inc. High-purity steviol glycosides
JP2022513616A (en) * 2018-11-27 2022-02-09 ピュアサークル ユーエスエー インコーポレイテッド High-purity steviol glycoside
CN113508124A (en) * 2019-02-15 2021-10-15 谱赛科美国股份有限公司 High-purity steviol glycosides
JP2022520257A (en) * 2019-02-15 2022-03-29 ピュアサークル ユーエスエー インコーポレイテッド High-purity steviol glycoside
WO2020168312A1 (en) * 2019-02-15 2020-08-20 Purecircle Usa Inc. High-purity steviol glycosides
US12378590B2 (en) 2019-02-15 2025-08-05 Purecircle Usa Inc. High-purity steviol glycosides
CN110656150A (en) * 2019-10-30 2020-01-07 山东三元生物科技股份有限公司 Preparation method of rebaudioside E, and product and application thereof

Similar Documents

Publication Publication Date Title
CN105348337B (en) Stevia rebaudianum sugar derivatives prepared by a kind of stevioside bioconversion, preparation method and applications
CN104726523B (en) Method for preparing rebaudioside M by enzyme method
CN109750071A (en) Method for synthesizing rebaudioside M through biocatalysis
CN106471128A (en) A method for enzymatically preparing rebaudioside M
CN106754595B (en) A Recombinant Bacteria and Its Application in Catalyzing Rebaudioside A to Rebaudioside D
CN108913641B (en) A kind of recombinant Escherichia coli and its application
CN105838759A (en) Preparation method of stevia sugar derivative
CN106834389A (en) Method for preparing rebaudioside M2 by catalyzing rebaudioside A through recombinant bacteria
CN104404065A (en) Mangosteen glycosyltransferase gene UGT74AC1 and application thereof
CN114875054B (en) A method for enzymatic preparation of glycosylated steviol glycoside compounds and their derivatives
CN110172486A (en) A method of synthesis 2'-Fucosyl lactose
CN108013306A (en) The preparation method of juice drinks rich in psicose
CN105380224A (en) Novel stevioside derivative, preparation method and application thereof
CN105255805B (en) Bacillus subtilis genetic engineering strain, construction method thereof and application thereof in lactulose production
CN107164435B (en) Preparation method of rebaudioside KA
CN105732740A (en) Preparation method of novel sweetening agent
CN105777824A (en) Stevioside derivative and application of stevioside derivative
CN101343618A (en) Preparation method of natural theanine
CN105820199A (en) Preparation method for novel stevioside derivative
CN111500601B (en) Myricetus flavonol 3-O-rhamnosyltransferase gene and encoded protein and application
CN105803021A (en) Preparing method for sweetening agent
CN105777823A (en) Sweetener and application of sweetener
JP3650632B2 (en) Recombinant enzyme that converts maltose to trehalose
CN112852843A (en) Flavonol 3-O-galactosyltransferase gene and encoding protein and application thereof
CN105837644A (en) Novel sweetening agent and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160810

WD01 Invention patent application deemed withdrawn after publication